Could oral antiviral pills be a game-changer for COVID-19? An infectious disease physician explains why these options are badly needed

Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.

Leave a comment

Your email address will not be published. Required fields are marked *